Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Change in Account Payables (2016 - 2026)

Apyx Medical filings provide 15 years of Change in Account Payables readings, the most recent being -$155000.0 for Q4 2025.

  • On a quarterly basis, Change in Account Payables fell 120.5% to -$155000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $355000.0, a 663.49% increase, with the full-year FY2025 number at $355000.0, up 663.49% from a year prior.
  • Change in Account Payables hit -$155000.0 in Q4 2025 for Apyx Medical, down from $328000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $782000.0 in Q1 2021 to a low of -$776000.0 in Q1 2023.
  • Median Change in Account Payables over the past 5 years was $169000.0 (2022), compared with a mean of $76900.0.
  • The widest YoY moves for Change in Account Payables: up 792.86% in 2023, down 1421.57% in 2023.
  • Apyx Medical's Change in Account Payables stood at -$401000.0 in 2021, then soared by 226.18% to $506000.0 in 2022, then increased by 26.09% to $638000.0 in 2023, then increased by 18.5% to $756000.0 in 2024, then tumbled by 120.5% to -$155000.0 in 2025.
  • The last three reported values for Change in Account Payables were -$155000.0 (Q4 2025), $328000.0 (Q3 2025), and $513000.0 (Q2 2025) per Business Quant data.